Literature DB >> 10781410

Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction.

I Tamir1, J M Dal Porto, J C Cambier.   

Abstract

One of the areas of greatest recent progress in immunology has been the elucidation of inhibitory receptors and their mode of signal transduction. A common feature of members of this growing family is expression of a conserved cytoplasmic sequence motif, the immunoreceptor tyrosine-based inhibitory motif, which functions to recruit and activate phosphatases that mediate the receptors' function. Family members include the protein tyrosine phosphatases SHP-1 (Src-homology-2-domain-containing protein tyrosine phosphatase 1) and SHP-2, which function to dephosphorylate key intermediaries in antigen receptor signaling pathways. Surprisingly, whereas most data to date support a role for SHP-1 in inhibitory signaling, SHP-2 exhibits distinct functions that appear to positively regulate receptor function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781410     DOI: 10.1016/s0952-7915(00)00092-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  27 in total

Review 1.  B cell inhibitory receptors and autoimmunity.

Authors:  Nicholas R Pritchard; Kenneth G C Smith
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.

Authors:  Ying-Hong Feng; Yan Sun; Janice G Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

3.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.

Authors:  Geraldine Ferjoux; Frederic Lopez; Jean-Pierre Esteve; Audrey Ferrand; Eric Vivier; Frederic Vely; Nathalie Saint-Laurent; Lucien Pradayrol; Louis Buscail; Christiane Susini
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

4.  Glycodelin-A protein interacts with Siglec-6 protein to suppress trophoblast invasiveness by down-regulating extracellular signal-regulated kinase (ERK)/c-Jun signaling pathway.

Authors:  Kevin K W Lam; Philip C N Chiu; Cheuk-Lun Lee; Ronald T K Pang; Carmen O N Leung; Hannu Koistinen; Markku Seppala; Pak-Chung Ho; William S B Yeung
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

5.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

6.  Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation.

Authors:  Keisuke Maeshima; Stephanie M Stanford; Deepa Hammaker; Cristiano Sacchetti; Li-Fan Zeng; Rizi Ai; Vida Zhang; David L Boyle; German R Aleman Muench; Gen-Sheng Feng; John W Whitaker; Zhong-Yin Zhang; Wei Wang; Nunzio Bottini; Gary S Firestein
Journal:  JCI Insight       Date:  2016-05-19

Review 7.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

8.  B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity.

Authors:  Ashraf M Khalil; John C Cambier; Mark J Shlomchik
Journal:  Science       Date:  2012-05-03       Impact factor: 47.728

9.  FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling.

Authors:  Hae Won Sohn; Peter D Krueger; Randall S Davis; Susan K Pierce
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

10.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse.

Authors:  To-Ha Thai; Heide Christine Patterson; Duc-Hung Pham; Katalin Kis-Toth; Denise A Kaminski; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.